top of page
The latest on cardiometabolic disease and Covid-19
Search
Prevalence and contamination risk associated with Diabetes, a meta-analysis
Quality of evidence: B+ Prevalence and Impact of Diabetes Among People Infected With SARS-CoV-2 Authors: Fadini GP et al. Journal: The...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Management of critically ill adults, a guideline summary for practioners
Quality of evidence: B- Management of Critically Ill Adults With COVID-19 Authors: Poston JT et al. Journal: JAMA Objectives: Centralize...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Hydroxychloroquine/Azithromycin combination and QTc, an expert recommendation
Quality of evidence: D- Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment Authors:...
Abderrahim Benmoussa, phD
Apr 14, 20201 min read
D-Dimer associated with severity, a pooled analysis
Quality of evidence: C+ D-dimer is Associated with Severity of Coronavirus Disease 2019: A meta-analysis Authors: Lippi et al. Journal: ...
Abderrahim Benmoussa, phD
Apr 14, 20201 min read
Effect of coronaviruses on the cardiovascular system, a systematic review
Strength of evidence: B - Potential Effects of Coronaviruses on the Cardiovascular. A System Review Authors: Madjid et al. Journal: JAMA...
Abderrahim Benmoussa, phD
Apr 14, 20201 min read
COVID-19 and cardiovascular disease, a narrative review
Quality of evidence: B+ Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease Authors: Clerkin et al. Journal: Circulation...
Abderrahim Benmoussa, phD
Apr 8, 20201 min read
Nomogram for early prediction of risk, a multicenter retrospective study
Quality of evidence: B A Tool to Early Predict Severe 2019-Novel Coronavirus Pneumonia (COVID-19): A Multicenter Study using the Risk...
Abderrahim Benmoussa, phD
Apr 8, 20201 min read
COVID-19 and the cardiovascular system, a review of the literature
Quality of evidence: B+ COVID-19 and the cardiovascular system Authors: Zheng et al. Journal: Nature Reviews Cardiology (2020)...
Abderrahim Benmoussa, phD
Apr 8, 20201 min read
Cardiovascular implications in fatality, a retrospective monocentric study
Quality of evidence: C Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Authors: Guo T...
Abderrahim Benmoussa, phD
Apr 7, 20201 min read
Experimental treatments and controversies, a review
Quality of evidence: C Controversial treatments: an updated understanding of the Coronavirus Disease 2019 Authors: Zhang C et al Journal:...
Abderrahim Benmoussa, phD
Apr 7, 20202 min read
Heparin and mortality in patients with coagulopathy, a retrospective cohort study
Quality of evidence: B- Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with...
Abderrahim Benmoussa, phD
Apr 7, 20201 min read
Early use of short term corticosteroids therapy, an open-label non-randomized monocentric trial
Quality of evidence: C- Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID-19...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Clinical features associated with fatality, a retrospective cohort study
Quality of evidence: C Clinical characteristics of 113 deceased patients with coronavirus disease 2019: a retrospective study Authors:...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Anti-inflammatory drugs and severe cases, a review, and expert position from China
Quality of evidence: C+ The Use of Anti-Inflammatory Drugs in the Treatment of People With Severe Coronavirus Disease 2019 (COVID-19):...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
CFR and characteristics linked to fatality, a short summary of Italian cases
Quality of evidence: C- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy Authors: Onder G et al...
Abderrahim Benmoussa, phD
Apr 6, 20201 min read
Clinical features in severe pediatric patients with COVID-19, An observational study
Quality of evidence: D Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center’s...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
Withdrawing renin-angiotensin inhibitors in COVID-19? A short review of the literature
Quality of evidence: D SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19? Authors:...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
Outcomes in severely ill patients, a multicentric retrospective cohort study (50 US states)
Quality of evidence: C Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) Authors: CDC COVID-19 Response Team...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
On Ibuprofen-associated risk during COVID-19, a news story
Quality of evidence: C- Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists Authors: Michael Day...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
Liver injury and severe coronavirus infections, a summary of the evidence
Quality of evidence: C+ Liver injury during highly pathogenic human coronavirus infections Authors: Xu L et al. Journal: Liver...
Abderrahim Benmoussa, phD
Apr 5, 20201 min read
bottom of page